ID   HKA-1
AC   CVCL_2943
SY   HKA1
DR   BioSample; SAMN03472533
DR   cancercelllines; CVCL_2943
DR   Cell_Model_Passport; SIDM01620
DR   DepMap; ACH-001521
DR   JCRB; JCRB1017
DR   JCRB; NIHS0251
DR   Wikidata; Q54889738
RX   CelloPub=CLPUB00048;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~34 hours (Note=At 37th passage) (CelloPub=CLPUB00048).
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Unspecified (DepMap=ACH-001521).
CC   Omics: Deep exome analysis.
CC   Discontinued: JCRB; NIHS0251; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): DepMap=ACH-001521; JCRB=JCRB1017
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 10
ST   D18S51: 13,16
ST   D21S11: 30,30.2
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 7,12
ST   D8S1179: 10
ST   FGA: 19,20
ST   Penta D: 9,13
ST   Penta E: 11,15
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C3146; Keratoacanthoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 23
//
RX   CelloPub=CLPUB00048;
RA   Hozumi Y.;
RT   "Establishment and characterization of a cell line (HKA-1) derived
RT   from a human skin keratoacanthoma.";
RL   Bull. Yamagata Univ. Med. Sci. 10:15-24(1992).
//